Immunohistochemical study of PSA in prostatic cancer

A. I. Karseladze*, I. E. Rytin, I. V. Budunova

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Prostate-specific antigen (PSA) is secreted both by normal epithelial prostatic cells and cells of prostatic carcinoma (PC). No parallelism exists between the degree of PC differentiation and the type of PSA secretion. PSA concentration in the peripheral bood not always corresponds to the intensity of its immunoreactivity on the tissue level. Amount of PSA in the blood depends on the stroma vascularisation and number of cells contacting with the organ stroma. A decrease of PSA in the peripheral blood due to therapy may be combined with high intensity of its synthesis in tumor cells. PSA immunohistochemistry may be recommended as a method of PC clinical course monitoring and dynamics of its changes in the course of carcinoma therapy.

Original languageEnglish (US)
Pages (from-to)3-7
Number of pages5
JournalArkhiv Patologii
Issue number2
StatePublished - 2004

ASJC Scopus subject areas

  • Pathology and Forensic Medicine


Dive into the research topics of 'Immunohistochemical study of PSA in prostatic cancer'. Together they form a unique fingerprint.

Cite this